A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety
Part of paid clinical trials in Mesa, Arizona.
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Study ID
- NCT01712178
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Adalimumab, current formulation — BIOLOGICALCurrent formulation adalimumab 40 mg every other week
- Adalimumab, new formulation — BIOLOGICALNew formulation adalimumab 40 mg every other week
Study Details
A study in Rheumatoid Arthritis (RA) patients to evaluate two formulations of adalimumab for pharmacodynamics, pharmacokinetics, and safety.
Key Dates
- Start date
- Jun 30, 2012
- Status verified
- Jun 2014
- Primary completion
- May 31, 2013
- Completion
- May 31, 2013
Study Design
- Enrollment
- 100 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: New formulation of adalimumab 40 mg every other weekNew formulation adalimumab 40 mg every other week
- Active Comparator: Current formulation adalimumab 40 mg every other weekCurrent formulation adalimumab 40 mg every other week
Primary Outcome Measure
Serum Concentrations of Adalimumab at Weeks 12 and 24 [ Time Frame: Measured at Weeks 12 and 24 ]
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Site Reference ID/Investigator# 75073 | Mesa | Arizona | 85202 | - |
| Site Reference ID/Investigator# 75077 | Hemet | California | 92543 | - |
| Site Reference ID/Investigator# 75076 | Wichita | Kansas | 67203 | - |
| Site Reference ID/Investigator# 75075 | Clifton | New Jersey | 07012 | - |
| Site Reference ID/Investigator# 83133 | Philadelphia | Pennsylvania | 19152 | - |
| Site Reference ID/Investigator# 75074 | Charleston | South Carolina | 29406 | - |
Find similar trials in Mesa, AZ
By condition
By research site
Site Reference ID/Investigator# 75073· Mesa, AZSite Reference ID/Investigator# 75077· Hemet, CASite Reference ID/Investigator# 75076· Wichita, KSSite Reference ID/Investigator# 75075· Clifton, NJSite Reference ID/Investigator# 83133· Philadelphia, PASite Reference ID/Investigator# 75074· Charleston, SC
Related Studies
- Physica System Total Knee Replacement Registry StudyRecruiting · Limacorporate S.p.a · Rancho Mirage, California
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- RA-PRO PRAGMATIC TRIALPHASE3 · Recruiting · University of Alabama at Birmingham · Auburn, Alabama
- Effect of Anti-inflammatory Diet in Rheumatoid ArthritisRecruiting · University of California, San Diego · La Jolla, California